Insider Transactions in Q3 2022 at Vanda Pharmaceuticals Inc. (VNDA)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 26
2022
|
Gunther Birznieks SVP, Business Development |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+0.65%
|
$3,750
$3.12 P/Share
|
|
Aug 22
2022
|
Joakim Wijkstrom SVP, Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
3,605
-3.6%
|
$36,050
$10.27 P/Share
|
|
Aug 15
2022
|
Timothy Williams SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
8,300
-4.08%
|
$83,000
$10.32 P/Share
|
|
Jul 28
2022
|
Kevin Patrick Moran SVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
2,239
-1.87%
|
$22,390
$10.97 P/Share
|